BILLERICA, Mass., March 14, 2018 /PRNewswire/ -- Bruker today announced that it has appointed Gerald N. Herman to serve as the Company's Interim Chief Financial Officer (CFO), effective as of March 17, 2018.
赫尔曼先生最近也被任命为布鲁克的首席会计官（PAO），他将在现任CFO Anthony L. Mattacchione离开后承担临时CFO的额外责任，他的辞职于2018年2月宣布。
Frank H. Laukien, President and CEO of Bruker Corporation, stated: "I am very pleased to have Gerald as our Interim Chief Financial Officer and on my Executive Leadership Team. His diverse and deep background in finance and operations, including extensive international and manufacturing experience, will enable Gerald to be a strong Interim CFO for Bruker. Gerald's process, systems and operational focus are a great fit for the continued execution of Bruker's dual strategy of portfolio transformation and operational excellence. I look forward to working with Gerald on our key operational priorities and profitable growth initiatives, and to continuing to deliver on our financial commitments."
Mr. Herman joined the Company in 2016 as Vice President and Corporate Controller. Prior to joining Bruker, Mr. Herman had served in senior executive positions with various publicly traded companies, including as Corporate Vice President - Clinical Operations of PAREXEL International from 2014 to February 2016, and as Corporate Vice President & Controller-Finance of PAREXEL from 2008 to 2013. Prior to 2008, Mr. Herman was Vice President - Corporate Controller of Presstek, Inc. He also served in financial, consulting and accounting roles at various organizations, including as Senior Manager at Arthur Andersen LLP from 1979 to 1987. Mr. Herman is a Certified Public Accountant (CPA) and holds a Master of Business Administration (MBA) from the University of Chicago, and a Master of Science in Taxation from Bentley University.
Mr. Herman commented: "Bruker is a leader in the life science tools markets and carries an outstanding legacy of innovation and customer success. I am excited about the opportunity to work more closely with Frank and our strong leadership team to continue to support discoveries for our customers and drive value for our shareholders."
Mr. John Ornell, the Chair of the Audit Committee of Bruker's Board of Directors, added: "Gerald is an integral member of Bruker's senior finance leadership team and he has been heavily involved with the Company's margin enhancement initiatives, which will continue to be his focus as Interim CFO. I look forward to working closely with Gerald."
About Bruker Corporation (NASDAQ: BRKR)
在超过55年的时间里，布鲁克（Bruker）使科学家能够做出突破性的发现，并开发了提高人类生活质量的新应用。布鲁克的高性能科学仪器以及高价值分析和诊断解决方案使科学家能够在分子，细胞和微观水平上探索生活和材料。bob综合游戏与我们的客户密切合作，布鲁克正在实现创新，提高生产率和客户在生命科学，应用和制药应用中，显微镜和纳米分析以及工业应用以及细胞生物学，陶艺成像，现象学，现象学，现象成像，现象应用方面的生产率和客户成功率。bob娱乐平台以及蛋白质组学研究，微生物学和分子病理学研究。有关更多信息，请访问：www.energie2point0.com.
Investor Contact:
Miroslava Minkova
Head of Investor Relations
Bruker Corporation
t：+1（978）663 - 3660，分机。1479年
E:miroslava.minkova@bruker.com
View original content with multimedia:http://www.prnewswire.com/news-releases/bruker-appoints-gerald-herman-as-interim-chief-financial-officer-300613685.html
SOURCE Bruker Corporation